ReviewThe Plant cell2025
Storming the barricades of rhamnogalacturonan-II synthesis and function.
Review in The Plant cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- AtGPP2 encodes a 3-deoxy-manno-octulosonate-8-phosphatase required for the synthesis of KDO in rhamnogalacturonan II.The Plant journal : for cell and molecular biology · 2026Article
- Plant cell wall remodeling and peptide signaling under abiotic and biotic stress.Plant communications · 2026Review
- A characterization of recombinant Arabidopsis FRIABLE1 (FRB1) reveals robust rhamnogalacturonan-I rhamnosyltransferase activity and critical catalytic residues.The Journal of biological chemistry · 2026Article
- Integrated physiological, multi-omics analyses reveal key factors underlying seed abortion inFrontiers in plant science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Despite its low abundance, rhamnogalacturonan-II (RG-II) is an essential structural component of the cell wall and is present in a highly conserved molecular configuration across all plants. RG-II is a branched pectin domain that contains 13 different sugars linked by over 20 different bond types, and uniquely among pectins it can be covalently dimerized via borate diesters. RG-II is hypothesized to crosslink the pectin matrix, controlling cell wall architecture and porosity, but has resisted detailed analyses due to its compositional complexity and the lethality of RG-II-deficient mutants. Here, we highlight how biochemical dissection, genetic engineering, chemical inhibitors, and high-resolution imaging have enabled recent leaps in our understanding of RG-II structure, synthesis, localization, dimerization, and function, pointing out new questions and research directions that have been enabled by these advances.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.